TITLE

Children's health products recalled

AUTHOR(S)
Panetta, Emily
PUB. DATE
June 2010
SOURCE
CMAJ: Canadian Medical Association Journal;6/15/2010, Vol. 182 Issue 9, pE422
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a reprint of the article regarding the funds donated to help fight against AIDS, which appeared at www.cmaj.ca between April 20 and May 18, 2010. The U.S. Food and Drug Administration says that the over-the-counter liquid health products for children and infants manufactured by McNeil Consumer Healthcare like Zyrtec® are being recalled due to the flaws in the manufacturing process. Meanwhile, the firm will conduct quality assessment on its manufacturing operations.
ACCESSION #
52224153

 

Related Articles

  • Substandard manufacturing prompts FDA recall of PediaCare products. Foster, Melissa // Infectious Diseases in Children;Jul2010, Vol. 23 Issue 7, p29 

    The article reports on the recall of PediaCare products from Blacksmith Brands by the U.S. Food and Drug Administration (FDA) due to poor quality manufacturing at the McNeil Consumer Healthcare plant.

  • McNeil OTC products recall.  // Monthly Prescribing Reference;Jun2010, Vol. 26 Issue 6, pA.18 

    The article reports on the notification given by the Food and Drug Administration (FDA) and McNeil Consumer Healthcare to healthcare professionals on the recall of some over-the-counter (OTC) children's and infant's liquid medications, including Tylenol, Motrin, Zyrtec and Benadryl, for failure...

  • FDA recalls liquid products for infants, children.  // Infectious Diseases in Children;Jun2010, Vol. 23 Issue 6, p45 

    The article reports that the U.S. Food and Drug Administration (FDA) and McNeil Consumer Healthcare are working together for the recall of all infant and children's liquid products of the latter, which include Tylenol and Benadryl.

  • Nine Ideas to Make Tylenol and Other Acetaminophen Drugs Safer. Engelberg, Stephen; Fields, Robin // Pro Publica;9/25/2013, p1 

    The article reports on drug safety issues involving popular drugs in the U.S. including acetaminophen, the active ingredient of Tylenol, and the issues of deaths and injuries resulting from drug misuse. The author discusses the proposals by institutions like the U.S. Centers for Disease Control...

  • FDA pressure leads Johnson & Johnson subsidiary to shut down U.S. drug plant.  // Material Handling Management;May2010, Vol. 65 Issue 5, p6 

    The article reports on the issue concerning the product recall issued to McNeil Consumer Healthcare by the U.S. Food & Drug Administration (FDA). It indicates that FDA also made allegations regarding the quality deficiencies in the drugmaker's manufacturing operations. McNeil made a product...

  • McNeil Controversy Spurs Call for Mandatory FDA Recall Power. Young, Donna // BioWorld Today;6/1/2010, Vol. 21 Issue 104, p3 

    The article analyzes the plan of the U.S. House Oversight and Government Reform Committee to make a law which will give the U.S. Food and Drug Authority (FDA) mandatory recall authority following the removal of more than 136 million bottles of children's medicines of McNeil Consumer Healthcare...

  • Nielsen: Tylenol Pulled TV Ads Before U.S. Recall. Edwards, Jim // Brandweek;5/31/2010, Vol. 51 Issue 22, p6 

    The article reports on the decision of McNeil Consumer Healthcare to withdraw all of its television advertising for Tylenol a month before closing its factory in Fort Washington, Pennsylvania. McNeil has confirmed that the voluntary recall of children's and infants' liquid Tylenol products were...

  • Peco Pallet Issues Statement on Recalls.  // Material Handling Management;Feb2010, Vol. 65 Issue 2, p10 

    The article reports on the statement issued by Peco Pallet Inc. regarding McNeil Consumer Healthcare's recall on its Tylenol Arthritis and over-the-counter drugs. According to the statement, drugs manufactured at its Puerto Rican plant were discovered containing tribromoanisole (TBA). It also...

  • Fallout from McNeil Recall Escalates. Wechsler, Jill // Pharmaceutical Executive;Jul2010, Vol. 30 Issue 7, p14 

    The article reports on the legal problems faced by Johnson & Johnson after the recall of children's medications of its subsidiary McNeil Consumer Healthcare in the U.S. It mentions that congressional committees of the Food & Drug Administration (FDA) have accused the company of delaying...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics